Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
FREEDOMS II study of fingolimod in RRMS
NCT00355134Phase 3Completed
- Sponsor
- Novartis
- Start
- Jun 2006
- Primary completion
- Jun 2011
- Modality
- Small Molecules
- Countries
- 8
01
Overview
A Phase 3 trial of fingolimod in relapsing-remitting multiple sclerosis (RRMS), sponsored by Novartis. Started Jun 2006; status: completed.
02
Drugs
fingolimod
03
Conditions
relapsing-remitting multiple sclerosis (RRMS)
Beyond the preview
Go deeper on NCT00355134.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00355134.